Results 141 to 150 of about 274,397 (324)

Atrial fibrosis in atrial fibrillation: Mechanisms, mapping techniques and clinical applications

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Summary of key aspects of atrial fibrosis in atrial fibrillation, highlighting atrial fibrosis as a hallmark of atrial fibrillation (AF). (1) Different types of fibrosis (blue), illustrating reparative and reactive fibrosis; (2) fibrosis detection techniques (green), illustrating late gadolinium enhancement cardiac magnetic ...
Caterina Vidal Horrach   +8 more
wiley   +1 more source

Linear and Nonlinear Correlations Between Surface and Invasive Atrial Activation Features in Catheter Ablation of Paroxysmal Atrial Fibrillation

open access: green, 2021
Aikaterini Vraka   +5 more
openalex   +2 more sources

Deciphering pro‐arrhythmogenic mechanisms of EPAC in human atrial cardiomyocytes

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend This study aimed to investigate the effect of exchange proteins directly activated by cAMP (EPAC) on the regulation of human atrial cardiomyocyte electrophysiology and their potential involvement in the onset of atrial fibrillation (AF).
Arthur Boileve   +11 more
wiley   +1 more source

Left atrial functions in the early period after cryoballoon ablation for paroxysmal atrial fibrillation [PDF]

open access: bronze, 2023
Ali Uğur Soysal   +10 more
openalex   +1 more source

Small‐conductance Ca2⁺‐activated K⁺ channels in cardiac excitation–contraction coupling: Bridging mitochondria, sarcolemma and antiarrhythmic therapy

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Mitochondrial SK channel enhancement reduces cardiac arrhythmia trigger. Spontaneous sarcoplasmic reticulum (SR) Ca2+ release via hyperactive RyR2s underlies an increased arrhythmia trigger, promoting early and delayed afterdepolarizations during stress. Hyperactive RyR2s causes rise in cytosolic [Ca2+] during diastole. Clearance
Dmitry Terentyev   +7 more
wiley   +1 more source

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES

open access: yesРоссийский кардиологический журнал, 2003
The work has studied opportunities for ТЕ EPS in serial testing of antiarrhythmic drugs testing to prevent recurrent arrhythmia in patients with atrial fibrillation.
K. A. Skiba, V. V. Petry, V. A. Sulimov
doaj  

Anteroposterior Diameter of the Left Atrium Determines the Occurrence of Left Atrial Tachycardia in Non-paroxysmal Atrial Fibrillation Patients after Catheter Ablation

open access: yesMajalah Kardiologi Indonesia
Objectives:             The relationship between left atrial (LA) size and atrial fibrillation (AF) is well-established. However, the specifics of LA regional remodeling and its connection to left atrial tachycardia (LA-AT) post-ablation in patients ...
Dicky Armein Hanafy   +5 more
doaj   +1 more source

Inpatient Outcomes of Atrial Fibrillation in Patients With Acute Pancreatitis: Insights From the TriNetX Database

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
There was a statistically significant increase in all cause mortality, patients requiring ICU level of care, acute kidney injury, deep venous thrombosis, hemorrhage, and severe sepsis in patients hospitalized for acute pancreatitis with atrial fibrillation as compared to those without atrial fibrillation between 2010 and 2024.
Obaid Ur Rehman   +9 more
wiley   +1 more source

860 Atrial pacing algorithms vs. high atrial pacing rate in the prevention of atrial fibrillation paroxysms [PDF]

open access: bronze, 2005
A.G. Manolis   +5 more
openalex   +1 more source

Biomarkers in paroxysmal atrial fibrillation

open access: yesHeart - Lung (Varna), 2011
През последните десетилетия заболеваемостта от предсърдномъждене(ПМ) сеувеличизначително, поради редица причини като застаряване на населението, подобрен терапевтичен подход и повишена преживяемост на пациентите със сърдечно-съдови заболявания. ПМ се асоциира с по-голям брой хоспитализации, влошено качество на живот и повишена смъртност.
M. Negreva, A. Penev
openaire   +2 more sources

Home - About - Disclaimer - Privacy